Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018
U.S. orphan drugs with patents and orphan drug exclusivity as of 2018
This statistic depicts the number of orphan drugs in the U.S. that were protected by patents or other distinctions as of 2018. According to the data, 205 drug were still protected by orphan drug exclusivity and patent exclusivity.
Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018
Number of drugs
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2018

Region

United States

Survey time period

as of November 2018

Number of respondents

503 respondents

Special properties

drugs with any approved orphan designation

Supplementary notes

ODE = orphan drug exclusivity.
Patent protection includes other forms of market exclusivity (e.g., pediatric extension, 505(b)(2)). The 101 therapies no longer protected by either ODE or patent exclusivity did not have generic competitors as of June 2018. The 116 therapies no longer protected by either ODE or patent exclusivity currently have one or more generic or biosimilar competitors in the market.

U.S. orphan drugs with patents and orphan drug exclusivity as of 2018
This statistic depicts the number of orphan drugs in the U.S. that were protected by patents or other distinctions as of 2018. According to the data, 205 drug were still protected by orphan drug exclusivity and patent exclusivity.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Orphan drugs"
  • Market overview
The most important statistics
  • Companies
  • Products
  • Research and development
  • Rare diseases
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.